You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Lamivudine

Showing 26 - 50 of 885
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

HIV Trial in Puerto Rico, United States (Abacavir sulfate, lamivudine, and zidovudine, Lamivudine/zidovudine,

Completed
  • HIV Infections
  • Abacavir sulfate, lamivudine, and zidovudine
  • +2 more
  • Los Angeles, California
  • +7 more
Oct 28, 2021

HIV Trial in Bangkok, Chiang Mai, Chonburri (Lamivudine, nevirapine, and stavudine fixed-dose tablet, Lamivudine, Nevirapine)

Completed
  • HIV Infections
  • Lamivudine, nevirapine, and stavudine fixed-dose tablet
  • +3 more
  • Bangkok, Ratchathewi, Thailand
  • +3 more
Oct 29, 2021

HIV, Hepatitis B Trial (Telbivudine, Lamivudine, Efavirenz)

Withdrawn
  • HIV Infections
  • Hepatitis B
  • (no location specified)
Oct 28, 2021

HIV, Acute HIV Infection Trial in Chapel Hill, Durham (Dolutegravir 50 mg, Lamivudine 300 mg, Abacavir 600 mg)

Completed
Has Results
  • HIV
  • Acute HIV Infection
  • Dolutegravir 50 mg
  • +2 more
  • Chapel Hill, North Carolina
  • +1 more
Oct 22, 2021

HIV-1-infection Trial in Burkina Faso, Cameroon, Côte D'Ivoire (dolutegravir, atazanavir boosted with ritonavir, tenofovir +

Recruiting
  • HIV-1-infection
  • Bobo-Dioulasso, Burkina Faso
  • +4 more
Oct 14, 2021

Patients' Experiences and Perceptions of 3TC/DTG Dual Therapy

Active, not recruiting
  • HIV Infections
  • Cultural Domain Analysis
  • +2 more
  • Brighton, United Kingdom
    Royal Sussex County Hospital, Brighton, UK
May 18, 2022

HIV Trial in Johannesburg (Cabotegravir Injection [Apretude], Tenofovir disoproxil fumarate / emtricitabine (or lamivudine))

Not yet recruiting
  • HIV Infections
  • Cabotegravir Injection [Apretude]
  • Tenofovir disoproxil fumarate / emtricitabine (or lamivudine)
  • Johannesburg, Gauteng, South Africa
    Ezintsha, a division of Wits Health Consortium
Nov 13, 2023

HIV-1 Infection Trial (Doravirine/lamivudine/tenofovir disoproxil fumarate)

Completed
Has Results
  • HIV-1 Infection
  • Doravirine/lamivudine/tenofovir disoproxil fumarate
  • (no location specified)
Oct 7, 2021

HIV, Drug Resistance, Drug Drug Interaction Trial in Switzerland (DOR/DTG/3TC)

Not yet recruiting
  • HIV
  • +2 more
  • Basel, Switzerland
  • +6 more
Sep 7, 2023

HIV, Pregnancy Trial in Miami, Detroit, Memphis (Ritonavir, Lamivudine, Zidovudine)

Completed
  • HIV Infections
  • Pregnancy
  • Miami, Florida
  • +4 more
Oct 27, 2021

HIV, Pregnancy Trial in San Francisco, Boston, Bronx (Indinavir sulfate, Lamivudine, Zidovudine)

Completed
  • HIV Infections
  • Pregnancy
  • Indinavir sulfate
  • +2 more
  • San Francisco, California
  • +3 more
Oct 27, 2021

HIV Trial in Thailand (GPO-Vir Z30 tablet, Lamivudine, Nevirapine)

Completed
  • HIV Infections
  • GPO-Vir Z30 tablet
  • +3 more
  • Muang District, Chantaburi, Thailand
  • +3 more
Nov 3, 2021

HIV Trial in Austin (TRIUMEQ, DOVATO)

Completed
  • HIV Infections
  • Austin, Texas
    GSK Investigational Site
Sep 21, 2021

Human Immunodeficiency Virus Trial in Newark (Dolutegravir/Lamivudine)

Active, not recruiting
  • Human Immunodeficiency Virus
  • Newark, New Jersey
    Saint Michael's Medical Center
May 3, 2022

HIV Trial (DTG/3TC, Cabotegravir (CAB) LA, Rilpivirine (RPV) LA)

Not yet recruiting
  • HIV Infections
  • (no location specified)
Jun 13, 2023

Transgender Health, Gender Dysphoria, Transgender Women Trial in Philadelphia (Doravirine/Lamivudine/Tenofovir, Spironolactone

Completed
  • Transgender Health
  • +3 more
  • Philadelphia, Pennsylvania
    Clinical Research Unit at Thomas Jefferson University
Feb 1, 2023

Hiv, HIV, HIV Cardiomyopathy Trial in Denmark (Dolutegravir / Lamivudine Oral Tablet)

Recruiting
  • Hiv
  • +5 more
  • Dolutegravir / Lamivudine Oral Tablet
  • Aalborg, Denmark
  • +4 more
May 26, 2021

HIV, AIDS, Virologic Failure Trial (Maintenance on TLD treatment strategy, Individualized Care treatment strategy, Immediate

Not yet recruiting
  • HIV Infections
  • +2 more
  • Maintenance on TLD treatment strategy
  • +2 more
  • (no location specified)
May 9, 2022

HIV, Pregnancy Trial in United States (Nelfinavir mesylate, Lamivudine, Zidovudine)

Completed
  • HIV Infections
  • Pregnancy
  • Nelfinavir mesylate
  • +2 more
  • Los Angeles, California
  • +6 more
Oct 27, 2021

HIV-1-infection Trial in Johannesburg (Doravirine/Lamivudine/Tenofovir)

Recruiting
  • HIV-1-infection
  • Johannesburg, Gauteng, South Africa
  • +2 more
Jun 6, 2022

HIV Trial in Paris (Switch from an INSTI-based regimen to the non INSTI-based regimen combining TDF/3TC/Doravirine)

Not yet recruiting
  • HIV Infections
  • Switch from an INSTI-based regimen to the non INSTI-based regimen combining TDF/3TC/Doravirine
  • Paris, Ile De France, France
    Christine Katlama
Jul 26, 2022

HIV-1 Infection Trial in Yaoundé (Dolutegravir 50 mg, Tenofovir disoproxil fumarate 300 mg / lamivudine 300 mg, Efavirenz 400

Completed
  • HIV-1 Infection
  • Dolutegravir 50 mg
  • +2 more
  • Yaoundé, Cameroon
  • +2 more
Aug 26, 2021

Dolutegravir Plus Lamivudine Simplified Therapy

Recruiting
  • HIV/AIDS
  • DTG+ 3TC
  • Guangzhou, Guangdong, China
    Guangzhou 8th People's Hospital
Jul 19, 2021

HIV Trial in United States (Dolutegravir + Lamivudine FDC)

Completed
Has Results
  • HIV Infections
  • Dolutegravir + Lamivudine FDC
  • Birmingham, Alabama
  • +15 more
Sep 20, 2021

HIV-1 Trial in Bobo-Dioulasso (Lamivudine Oral Solution)

Active, not recruiting
  • HIV-1
  • Lamivudine Oral Solution
  • Bobo-Dioulasso, Burkina Faso
    Paulin Fao
Mar 29, 2022